BioCentury | Dec 14, 2018
Company News

AMAG to acquire Perosphere for $50M

...AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) will acquire Perosphere Pharmaceuticals Inc. (Danbury, Conn.) for $50 million up front...
...AMAG will also assume a $12 million term loan and up to $6.2 million of Perosphere's...
...January. Perosphere Pharmaceuticals Inc., Danbury, Conn. AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Waltham, Mass. Business: Hematology Sandi Wong AMAG Pharmaceuticals Perosphere Inc. ciraparantag Robert...
BioCentury | Jul 1, 2016
Company News

Management tracks

...Md.) named Patricia Mayer EVP of regulatory affairs. She was VP of regulatory affairs at Perosphere Inc....
BioCentury | Apr 27, 2015
Clinical News

PER977 regulatory update

...FDA granted Fast Track designation to PER977 from Perosphere for anticoagulant reversal. The company said it...
...the fall. PER977 is a small molecule that binds with heparin and new oral anticoagulants. Perosphere Inc....
BioCentury | Dec 11, 2014
Cover Story

Universal reversal for heparin

...very long time," said James Costin, CMO and VP of clinical and medical affairs at Perosphere Inc....
...is not completely dry for heparin reversal. At least two companies- Portola Pharmaceuticals Inc. and Perosphere-are...
...are specific for reversing heparin anticoagulants and are unlikely to neutralize direct factor Xa inhibitors. Perosphere's...
BioCentury | Apr 29, 2013
Company News

Perosphere, Daiichi Sankyo deal

...Daiichi Sankyo will co-sponsor a Phase I trial evaluating Perosphere's PER977 to reverse the anticoagulant activity...
...prevent recurrent VTE complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE). Perosphere...
...will not have rights to PER977 under the deal and additional details are not disclosed. Perosphere Inc....
BioCentury | Dec 19, 2011
Financial News

Perosphere completes venture financing

...Date completed: 12/19/11 Type: Venture financing Raised: $1 million Investors: Private investors; company management Note: Perosphere...
Items per page:
1 - 6 of 6
BioCentury | Dec 14, 2018
Company News

AMAG to acquire Perosphere for $50M

...AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) will acquire Perosphere Pharmaceuticals Inc. (Danbury, Conn.) for $50 million up front...
...AMAG will also assume a $12 million term loan and up to $6.2 million of Perosphere's...
...January. Perosphere Pharmaceuticals Inc., Danbury, Conn. AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Waltham, Mass. Business: Hematology Sandi Wong AMAG Pharmaceuticals Perosphere Inc. ciraparantag Robert...
BioCentury | Jul 1, 2016
Company News

Management tracks

...Md.) named Patricia Mayer EVP of regulatory affairs. She was VP of regulatory affairs at Perosphere Inc....
BioCentury | Apr 27, 2015
Clinical News

PER977 regulatory update

...FDA granted Fast Track designation to PER977 from Perosphere for anticoagulant reversal. The company said it...
...the fall. PER977 is a small molecule that binds with heparin and new oral anticoagulants. Perosphere Inc....
BioCentury | Dec 11, 2014
Cover Story

Universal reversal for heparin

...very long time," said James Costin, CMO and VP of clinical and medical affairs at Perosphere Inc....
...is not completely dry for heparin reversal. At least two companies- Portola Pharmaceuticals Inc. and Perosphere-are...
...are specific for reversing heparin anticoagulants and are unlikely to neutralize direct factor Xa inhibitors. Perosphere's...
BioCentury | Apr 29, 2013
Company News

Perosphere, Daiichi Sankyo deal

...Daiichi Sankyo will co-sponsor a Phase I trial evaluating Perosphere's PER977 to reverse the anticoagulant activity...
...prevent recurrent VTE complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE). Perosphere...
...will not have rights to PER977 under the deal and additional details are not disclosed. Perosphere Inc....
BioCentury | Dec 19, 2011
Financial News

Perosphere completes venture financing

...Date completed: 12/19/11 Type: Venture financing Raised: $1 million Investors: Private investors; company management Note: Perosphere...
Items per page:
1 - 6 of 6